Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

EBOS Group Ltd
ASX:EBO

Watchlist Manager
EBOS Group Ltd Logo
EBOS Group Ltd
ASX:EBO
Watchlist
Price: 20.33 AUD -3.6%
Market Cap: AU$3.9B
Write Note Create Alert Ask AI

Profitability Summary

EBOS Group Ltd's profitability score is 47/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

47/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

47/100
Profitability
Score
47/100
Profitability
Score

Margins

Earnings Waterfall
EBOS Group Ltd

Margins Comparison
EBOS Group Ltd Competitors

Country Company Market Cap Gross
Margin 		Operating
Margin 		Net
Margin
NZ
EBOS Group Ltd
NZX:EBO
4.9B NZD
Loading...
Loading...
Loading...
US
Mckesson Corp
NYSE:MCK
113.7B USD
Loading...
Loading...
Loading...
US
Cencora Inc
NYSE:COR
68.7B USD
Loading...
Loading...
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
70.7B USD
Loading...
Loading...
Loading...
US
Cardinal Health Inc
NYSE:CAH
51.4B USD
Loading...
Loading...
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
35.1B AUD
Loading...
Loading...
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
9.4B USD
Loading...
Loading...
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
64.3B CNY
Loading...
Loading...
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
63.9B CNY
Loading...
Loading...
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
66.4B HKD
Loading...
Loading...
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
EBOS Group Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
NZ
EBOS Group Ltd
NZX:EBO
4.9B NZD
Loading...
Loading...
Loading...
Loading...
US
Mckesson Corp
NYSE:MCK
113.7B USD
Loading...
Loading...
Loading...
Loading...
US
Cencora Inc
NYSE:COR
68.7B USD
Loading...
Loading...
Loading...
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
70.7B USD
Loading...
Loading...
Loading...
Loading...
US
Cardinal Health Inc
NYSE:CAH
51.4B USD
Loading...
Loading...
Loading...
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
35.1B AUD
Loading...
Loading...
Loading...
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
9.4B USD
Loading...
Loading...
Loading...
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
64.3B CNY
Loading...
Loading...
Loading...
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
63.9B CNY
Loading...
Loading...
Loading...
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
66.4B HKD
Loading...
Loading...
Loading...
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
EBOS Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

See Also

Summary
EBO intrinsic value, competitors valuation, and company profile.
DCF Valuation
EBO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EBO stock valuation using valuation multiples.
Wall Street Estimates
EBO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EBO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 317,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.